AC Immune (ACIU) Change in Account Payables (2015 - 2025)
AC Immune's (ACIU) quarterly Change in Account Payables came in at $414137.2 in Q4 2025, down 70.79% year-on-year from $1.4 million in Q4 2024, and up 128.44% on a QoQ basis from -$1.5 million in Q3 2025.
AC Immune (ACIU) Change in Account Payables (2015 - 2025) Analysis & Trends
AC Immune (ACIU) has 11 years of Change in Account Payables data on file, last reported at $414137.2 in Q4 2025.
- On a quarterly basis, Change in Account Payables fell 70.79% year-over-year to $414137.2 in Q4 2025; TTM through Dec 2025 was -$713779.1, a 161.01% decrease from a year earlier, with the FY2025 full-year figure at -$714028.1, down 164.02% from the prior year.
- Change in Account Payables for Q4 2025 stood at $414137.2, up from -$1.5 million in the prior quarter.
- Over the last five years, Change in Account Payables for ACIU reached as high as $2.0 million in Q4 2021 and fell as low as -$2.0 million in Q1 2021.
- Historically, Change in Account Payables has averaged -$123.93 across 5 years, with a median of $64889.3 in 2023.
- Across the five-year window, Change in Account Payables soared 1678.46% in 2022 and tumbled 6541.05% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $2.0 million in 2021, then sank by 137.01% to -$727653.4 in 2022, then soared by 131.45% to $228853.0 in 2023, then jumped by 519.51% to $1.4 million in 2024, then plunged by 70.79% to $414137.2 in 2025.
- Per Business Quant data, the three most recent Change in Account Payables figures were $414137.2 in Q4 2025, -$1.5 million in Q3 2025, and $748891.9 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 414,137.20 |
| Dec 31, 2025 | 414,137.20 |
| Sep 30, 2025 | -1.46 Mn |
| Sep 30, 2025 | -1.46 Mn |
| Jun 30, 2025 | 748,891.94 |
| Jun 30, 2025 | 748,891.94 |
| Mar 31, 2025 | -420,430.70 |
| Mar 31, 2025 | -420,430.70 |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | -21,929.94 |
| Sep 30, 2024 | -21,929.94 |
| Jun 30, 2024 | -1.55 Mn |
| Jun 30, 2024 | -1.55 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 228,852.96 |
| Dec 31, 2023 | 228,852.96 |
| Sep 30, 2023 | 151,708.44 |
| Sep 30, 2023 | 151,708.44 |